Free Trial

MIRA Pharmaceuticals (MIRA) SEC Filings & 10K Form

MIRA Pharmaceuticals logo
$1.22 -0.01 (-0.81%)
Closing price 04:00 PM Eastern
Extended Trading
$1.20 -0.02 (-2.05%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent MIRA Pharmaceuticals SEC Filings

DateFilerForm TypeView
05/21/2025
4:25 PM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
6:30 AM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2025
6:30 AM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2025
6:30 AM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2025
4:28 PM
MIRA Pharmaceuticals (Filer)
Form 10-K/A
04/16/2025
4:17 PM
MIRA Pharmaceuticals (Filer)
Form 424B5
04/16/2025
6:30 AM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2025
4:15 PM
MIRA Pharmaceuticals (Filer)
Form 10-K/A
04/11/2025
4:15 PM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2025
6:30 AM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/24/2025
6:30 AM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2025
6:45 AM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2025
7:00 AM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2024
4:00 PM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2024
7:30 AM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2024
4:15 PM
Del Giudice Matthew Paul (Reporting)
MIRA Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
4:15 PM
MIRA Pharmaceuticals (Issuer)
Shekhat Denil Nanji (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
4:15 PM
Aminov Erez (Reporting)
MIRA Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
4:15 PM
MIRA Pharmaceuticals (Issuer)
Yanez Michelle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
4:15 PM
MacPherson Edward Clouston (Reporting)
MIRA Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
4:15 PM
MIRA Pharmaceuticals (Issuer)
Whalen Matthew Pratt (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
7:45 AM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2024
3:15 PM
Aminov Erez (Reporting)
MIRA Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
4:58 PM
Aminov Erez (Reporting)
MIRA Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/21/2024
6:00 AM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2024
4:20 PM
MIRA Pharmaceuticals (Filer)
Form 424B5
09/27/2024
3:45 PM
MIRA Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/12/2024
3:30 PM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
3:01 PM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2024
3:38 PM
McNulty Brian Patrick (Reporting)
MIRA Pharmaceuticals (Subject)
Form 144/A
09/04/2024
7:20 PM
McNulty Brian Patrick (Reporting)
MIRA Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/18/2024
11:15 PM
MIRA Pharmaceuticals (Filer)
Form EFFECT
08/12/2024
7:37 AM
MIRA Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/08/2024
7:54 AM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2024
3:49 PM
MIRA Pharmaceuticals (Filer)
Form DEF 14A
07/26/2024
3:55 PM
MIRA Pharmaceuticals (Filer)
Form DEFA14A
07/24/2024
3:07 PM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2024
4:12 PM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2024
4:00 PM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2024
3:30 PM
MIRA Pharmaceuticals (Issuer)
Shekhat Denil Nanji (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
5:00 PM
Aminov Erez (Reporting)
MIRA Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Trump’s treachery (Ad)

Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.

Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma
05/29/2024
7:30 AM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MIRA) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners